BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27712796)

  • 21. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
    Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
    PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cerebral MR imaging of malignant melanoma].
    Breckwoldt M; Bendszus M
    Radiologe; 2015 Feb; 55(2):113-9. PubMed ID: 25589420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain Tumors in the Neonate.
    Shekdar KV; Schwartz ES
    Neuroimaging Clin N Am; 2017 Feb; 27(1):69-83. PubMed ID: 27889024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CT and MRI of brain tumors.
    Bruzzone MG; D'Incerti L; Farina LL; Cuccarini V; Finocchiaro G
    Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):112-37. PubMed ID: 22617235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neuroimaging in brain tumors].
    Arbizu J; Domínguez PD; Diez-Valle R; Vigil C; García-Eulate R; Zubieta JL; Richter JA
    Rev Esp Med Nucl; 2011; 30(1):47-65. PubMed ID: 21211868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Diffusion Tensor Imaging and Magnetic Resonance Perfusion Imaging in Differentiating Recurrent Brain Neoplasm From Radiation Necrosis.
    Masch WR; Wang PI; Chenevert TL; Junck L; Tsien C; Heth JA; Sundgren PC
    Acad Radiol; 2016 May; 23(5):569-76. PubMed ID: 26916251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tumors of the posterior cranial fossa].
    Papanagiotou P; Politi M
    Radiologe; 2016 Nov; 56(11):967-975. PubMed ID: 27757491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging.
    Kimura T; Sako K; Tanaka K; Gotoh T; Yoshida H; Aburano T; Tanaka T; Arai H; Nakada T
    J Neurosurg; 2004 May; 100(5):835-41. PubMed ID: 15137602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain tumors: a multimodality approach with diffusion-weighted imaging, diffusion tensor imaging, magnetic resonance spectroscopy, dynamic susceptibility contrast and dynamic contrast-enhanced magnetic resonance imaging.
    Brandão LA; Shiroishi MS; Law M
    Magn Reson Imaging Clin N Am; 2013 May; 21(2):199-239. PubMed ID: 23642551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinomatous encephalitis (miliary metastases): lack of contrast enhancement.
    Nemzek W; Poirier V; Salamat MS; Yu T
    AJNR Am J Neuroradiol; 1993; 14(3):540-2. PubMed ID: 8517338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted Magnetic Resonance Imaging in Differentiating Recurrent Head and Neck Cancer From Postradiation Changes.
    Abdel Razek AA; Gaballa G; Ashamalla G; Alashry MS; Nada N
    J Comput Assist Tomogr; 2015; 39(6):849-54. PubMed ID: 26359584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of contrast enhancement in the brain and meninges.
    Smirniotopoulos JG; Murphy FM; Rushing EJ; Rees JH; Schroeder JW
    Radiographics; 2007; 27(2):525-51. PubMed ID: 17374867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. History and evolution of brain tumor imaging: insights through radiology.
    Castillo M
    Radiology; 2014 Nov; 273(2 Suppl):S111-25. PubMed ID: 25340432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic Glucose-Enhanced MR Imaging.
    Paech D; Radbruch A
    Magn Reson Imaging Clin N Am; 2021 Feb; 29(1):77-81. PubMed ID: 33237017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Extra-axial brain tumors].
    Papanagiotou P; Ketter R; Reith W
    Radiologe; 2012 Dec; 52(12):1129-46. PubMed ID: 23178788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging of the Sella and Parasellar Region in the Pediatric Population.
    Seeburg DP; Dremmen MH; Huisman TA
    Neuroimaging Clin N Am; 2017 Feb; 27(1):99-121. PubMed ID: 27889026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging.
    Cha S; Knopp EA; Johnson G; Wetzel SG; Litt AW; Zagzag D
    Radiology; 2002 Apr; 223(1):11-29. PubMed ID: 11930044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroimaging of Peptide-based Vaccine Therapy in Pediatric Brain Tumors: Initial Experience.
    Furtado AD; Ceschin R; Blüml S; Mason G; Jakacki RI; Okada H; Pollack IF; Panigrahy A
    Neuroimaging Clin N Am; 2017 Feb; 27(1):155-166. PubMed ID: 27889021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
    Warmuth C; Gunther M; Zimmer C
    Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraparenchymal brain metastases: MR imaging versus contrast-enhanced CT.
    Sze G; Shin J; Krol G; Johnson C; Liu D; Deck MD
    Radiology; 1988 Jul; 168(1):187-94. PubMed ID: 3380956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.